US
US Animal Vaccines Market Industry Trends and Forecast to 2034: Segmented by (Animal, Type, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
US · 2024–2034 · estimates
Values shown here are estimates. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
US (this report) at $5.04 Bn.
Canada at 7% a year.Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
$2.52 Bn total, 2026–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $4.82 Bn | — | — |
| 2025 (base) | $5.04 Bn | +$221.7 Mn | — |
| 2026 (forecast) | $5.27 Bn | +$231.9 Mn | +4.6% |
| 2027 (forecast) | $5.52 Bn | +$242.6 Mn | +9.4% |
| 2028 (forecast) | $5.77 Bn | +$253.8 Mn | +14.4% |
| 2029 (forecast) | $6.04 Bn | +$265.4 Mn | +19.7% |
| 2030 (forecast) | $6.31 Bn | +$277.6 Mn | +25.2% |
| 2031 (forecast) | $6.60 Bn | +$290.4 Mn | +31% |
| 2032 (forecast) | $6.91 Bn | +$303.8 Mn | +37% |
| 2033 (forecast) | $7.23 Bn | +$317.7 Mn | +43.3% |
| 2034 (forecast) | $7.56 Bn | +$332.4 Mn | +49.9% |
Estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
US (this report)
$5.04 Bn
China
$1.10 Bn
Canada
$1.06 Bn
Japan
$734.2 Mn
Germany
$451.4 Mn
France
$378.3 Mn
Italy
$335.3 Mn
Brazil
$336.4 Mn
UK
$308.0 Mn
Ecuador
$280.5 Mn
India
$249.4 Mn
Saudi Arabia
$244.1 Mn
Spain
$218.5 Mn
Mexico
$163.9 Mn
Russia
$144.8 Mn
Australia
$147.1 Mn
New Zealand
$132.0 Mn
South Africa
$86.2 Mn
UAE
$72.6 Mn
Egypt
$32.4 Mn
Philippines
$23.9 Mn
Hong Kong
$21.5 Mn
Malaysia
$18.5 Mn
Singapore
$15.0 Mn
Thailand
$14.8 Mn
Kenya
$9.9 Mn
Animal vaccines protect pets and livestock against infectious diseases such as rabies, foot-and-mouth disease and bird flu.
Key segments of the animal Vaccines market include animal (Livestock, Poultry and Companion Animals) and type (Live Attenuated, Inactivated and Recombinant).
More pets per household, owners treating pets as family, livestock disease risks and the One Health approach linking animal and human health are driving the animal Vaccines market.
Pet insurance, diagnostics and vaccines for emerging animal diseases give the animal Vaccines market room to grow.
Cost-sensitive farmers, fewer vets in rural areas, rules on antibiotic use in animals and slow approvals hold back the animal Vaccines market.
The animal Vaccines market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
Regulators such as the US FDA, the European Medicines Agency and national drug authorities set approval, pricing and safety rules for animal Vaccines. Reimbursement decisions by public payers and insurers shape how fast new therapies reach patients in US.
What doctors and scientists are doing in Animal Vaccines right now, from free public sources.
Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 14 Nov 2026.
[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 13 Nov 2026.
[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 13 Nov 2026.
[4] PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
OTC & Nutraceuticals · US
Healthcare Services · US
Medical Devices · US
Medical Devices · US
Digital Health · US
Healthcare Services · US